{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:53:44Z","timestamp":1791237224534,"version":"4.1.0"},"reference-count":44,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T00:00:00Z","timestamp":1621036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Cardiac disease is the leading cause of maternal mortality in the UK, so accurate cardiovascular diagnoses in pregnancy are essential. BNP (B-type natriuretic peptide) and NT-pro BNP (N-terminal-pro BNP) are useful clinical tools for investigating suspected peripartum cardiomyopathy but, as the pregnancy-specific reference intervals are undefined, it is uncertain how they should be interpreted in pregnant women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To define trimester-specific 95% reference intervals for BNP and NT-pro BNP in pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Longitudinal study of 260 healthy pregnant women, with sampling in each trimester.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The upper reference limit for NT-pro BNP was 200 pg\/mL in the first and second trimesters, and 150 pg\/mL in the third. Levels were significantly reduced in overweight women in the third trimester (P\u2005=\u2005.0001), which supports the partitioning of reference intervals by body mass index (BMI). The upper limit for BNP was 50 pg\/mL, with no detectable trimester-related differences. Although other biomarkers (hemoglobin and platelets) fell throughout pregnancy, both natriuretic peptides were initially elevated before falling by the third trimester, suggesting that the observed changes in natriuretic peptides are driven by dynamic interplay between cardiac strain and progressive hemodilution. NT-pro BNP in the first trimester was inversely associated with neonatal birthweight at term (P\u2005=\u2005.011).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cardiac biomarkers have an important role for investigating suspected disease in high-risk pregnant women, but a robust assessment of the levels expected in healthy pregnant women is an essential prerequisite to their application in clinical practice. This study has defined trimester- and BMI-specific reference intervals for NT-pro BNP and BNP, which may improve how women with suspected cardiovascular disease are investigated in pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvab091","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T00:38:30Z","timestamp":1621039110000},"source":"Crossref","is-referenced-by-count":45,"title":["Pregnancy-specific Reference Intervals for BNP and NT-pro BNP\u2014Changes in Natriuretic Peptides Related to Pregnancy"],"prefix":"10.1210","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1606-7213","authenticated-orcid":false,"given":"Samuel","family":"Dockree","sequence":"first","affiliation":[{"name":"Women\u2019s Centre, John Radcliffe Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Brook","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, John Radcliffe Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Shine","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, John Radcliffe Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"James","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, John Radcliffe Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Vatish","sequence":"additional","affiliation":[{"name":"Nuffield Department of Women\u2019s and Reproductive Health, University of Oxford, John Radcliffe Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,5,15]]},"reference":[{"issue":"1","key":"2021122821130631600_CIT0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ogrm.2018.12.003","article-title":"The findings of the MBRRACE-UK confidential enquiry into maternal deaths and morbidity","volume":"29","author":"Knight","year":"2019","journal-title":"Obstet Gynaecol Reprod Med."},{"key":"2021122821130631600_CIT0002","volume-title":"CG95. Recent-Onset Chest Pain of Suspected Cardiac Origin: Assessment and Diagnosis.","author":"National Institute for Health and Care Excellence.","year":"2010"},{"key":"2021122821130631600_CIT0003","volume-title":"NG106. Chronic Heart Failure in Adults: Diagnosis and Management.","author":"National Institute for Health and Care Excellence.","year":"2018"},{"issue":"10","key":"2021122821130631600_CIT0004","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.5603\/KP.2016.0141","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"74","author":"Ponikowski","year":"2016","journal-title":"Kardiol Pol."},{"issue":"6","key":"2021122821130631600_CIT0005","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart failure society of America","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation."},{"issue":"2","key":"2021122821130631600_CIT0006","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/heart.89.2.150","article-title":"NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function","volume":"89","author":"Bay","year":"2003","journal-title":"Heart."},{"issue":"1-2","key":"2021122821130631600_CIT0007","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2007.03.005","article-title":"Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly","volume":"382","author":"Alehagen","year":"2007","journal-title":"Clin Chim Acta."},{"issue":"4","key":"2021122821130631600_CIT0008","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10741-014-9447-6","article-title":"Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence","volume":"19","author":"Hill","year":"2014","journal-title":"Heart Fail Rev."},{"key":"2021122821130631600_CIT0009","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mehy.2018.09.034","article-title":"B-type natriuretic peptides in pregnant women with normal heart or cardiac disorders","volume":"121","author":"Balaceanu","year":"2018","journal-title":"Med Hypotheses."},{"issue":"6 Pt 1","key":"2021122821130631600_CIT0010","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0002-9378(89)90900-9","article-title":"Central hemodynamic assessment of normal term pregnancy","volume":"161","author":"Clark","year":"1989","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"2021122821130631600_CIT0011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5830\/CVJA-2016-021","article-title":"Physiological changes in pregnancy","volume":"27","author":"Soma-Pillay","year":"2016","journal-title":"Cardiovasc J Afr."},{"issue":"1","key":"2021122821130631600_CIT0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1753495X17736717","article-title":"NT-proBNP: when is it useful in obstetric medicine?","volume":"11","author":"Ker","year":"2018","journal-title":"Obstet Med."},{"issue":"6","key":"2021122821130631600_CIT0013","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.116.023005","article-title":"Sex-based differences in cardiometabolic biomarkers","volume":"135","author":"Lew","year":"2017","journal-title":"Circulation."},{"issue":"11","key":"2021122821130631600_CIT0014","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/HJH.0b013e3283300541","article-title":"Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers","volume":"27","author":"Rafik Hamad","year":"2009","journal-title":"J Hypertens."},{"issue":"6","key":"2021122821130631600_CIT0015","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/uog.19040","article-title":"Addition of N-terminal pro-B natriuretic peptide to soluble FMS-like tyrosine kinase-1\/placental growth factor ratio &gt;\u200938 improves prediction of pre-eclampsia requiring delivery within 1\u2009week: a longitudinal cohort study","volume":"51","author":"Sabri\u00e1","year":"2018","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"2","key":"2021122821130631600_CIT0016","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ehf2.12129","article-title":"Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis","volume":"4","author":"Alma","year":"2017","journal-title":"ESC Heart Fail."},{"issue":"10","key":"2021122821130631600_CIT0017","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1373\/clinchem.2005.054023","article-title":"Plasma concentrations of N-terminal pro-B-type natriuretic peptide in pregnant women near labor and during early puerperium","volume":"51","author":"Lev-Sagie","year":"2005","journal-title":"Clin Chem."},{"key":"2021122821130631600_CIT0018"},{"key":"2021122821130631600_CIT0019"},{"issue":"2","key":"2021122821130631600_CIT0020","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/0009-8981(87)90151-3","article-title":"Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits","volume":"170","author":"Solberg","year":"1987","journal-title":"Clinica Chimica Acta."},{"key":"2021122821130631600_CIT0021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2020.12.007","article-title":"A pregnancy-specific reference interval for procalcitonin","volume":"513","author":"Dockree","year":"2021","journal-title":"Clinica Chimica Acta."},{"issue":"Pt 5","key":"2021122821130631600_CIT0022","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1258\/acb.2008.008028","article-title":"Use of routine clinical laboratory data to define reference intervals","volume":"45","author":"Shine","year":"2008","journal-title":"Ann Clin Biochem."},{"issue":"12","key":"2021122821130631600_CIT0023","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/clinchem\/47.12.2137","article-title":"Effect of outliers and nonhealthy individuals on reference interval estimation","volume":"47","author":"Horn","year":"2001","journal-title":"Clin Chem."},{"issue":"6","key":"2021122821130631600_CIT0024","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-3016.2008.00969.x","article-title":"Assays with lower detection limits: implications for epidemiological investigations","volume":"22","author":"Whitcomb","year":"2008","journal-title":"Paediatr Perinat Epidemiol."},{"issue":"2","key":"2021122821130631600_CIT0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/clinchem\/48.2.338","article-title":"Objective criteria for partitioning Gaussian-distributed reference values into subgroups","volume":"48","author":"Lahti","year":"2002","journal-title":"Clin Chem."},{"issue":"4","key":"2021122821130631600_CIT0026","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2011.04.014","article-title":"Pregnancy in patients with pre-existing cardiomyopathies","volume":"58","author":"Stergiopoulos","year":"2011","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"2021122821130631600_CIT0027","first-page":"577","article-title":"B-type natriuretic peptide and echocardiography reflect volume changes during pregnancy","volume":"45","author":"Janet","year":"2017","journal-title":"J Perinat Med."},{"key":"2021122821130631600_CIT0028","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fped.2019.00271","article-title":"Cardiovascular biomarkers in amniotic fluid, umbilical arterial blood, umbilical venous blood, and maternal blood at delivery, and their reference values for full-term, singleton, cesarean deliveries","volume":"7","author":"Blohm","year":"2019","journal-title":"Front Pediatr."},{"issue":"1","key":"2021122821130631600_CIT0029","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1515\/cclm-2017-0433","article-title":"New issues on measurement of B-type natriuretic peptides","volume":"56","author":"Clerico","year":"2018","journal-title":"Clin Chem Lab Med (CCLM)."},{"issue":"6","key":"2021122821130631600_CIT0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jacc.2016.04.060","article-title":"A test in context: neprilysin: function, inhibition, and biomarker","volume":"68","author":"Bayes-Genis","year":"2016","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"2021122821130631600_CIT0031","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/HYPERTENSIONAHA.119.12707","article-title":"Placental syncytiotrophoblast-derived extracellular vesicles carry active NEP (neprilysin) and are increased in preeclampsia","volume":"73","author":"Gill","year":"2019","journal-title":"Hypertension."},{"issue":"9","key":"2021122821130631600_CIT0032","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.amjcard.2011.06.057","article-title":"Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study)","volume":"108","author":"Fradley","year":"2011","journal-title":"Am J Cardiol."},{"issue":"3","key":"2021122821130631600_CIT0033","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1677\/joe.0.1400393","article-title":"Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal human pregnancy and the postpartum period","volume":"140","author":"Yoshimura","year":"1994","journal-title":"J Endocrinol."},{"issue":"9","key":"2021122821130631600_CIT0034","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1158\/1055-9965.EPI-07-0311","article-title":"Plasma volume expansion in pregnancy: implications for biomarkers in population studies","volume":"16","author":"Faupel-Badger","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"2","key":"2021122821130631600_CIT0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/00016340802596025","article-title":"NT-proBNP is increased in healthy pregnancies compared to non-pregnant controls","volume":"88","author":"Franz","year":"2009","journal-title":"Acta Obstet Gynecol Scand."},{"key":"2021122821130631600_CIT0036","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12872-015-0063-8","article-title":"Association between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure","volume":"15","author":"Gaborit","year":"2015","journal-title":"BMC Cardiovasc Disord."},{"issue":"2","key":"2021122821130631600_CIT0037","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijoa.2012.11.001","article-title":"Utility of B-type natriuretic peptides in preeclampsia: a systematic review","volume":"22","author":"Afshani","year":"2013","journal-title":"Int J Obstet Anesth."},{"issue":"6","key":"2021122821130631600_CIT0038","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00404-014-3563-3","article-title":"The value of uterine artery Doppler and NT-proBNP levels in the second trimester to predict preeclampsia","volume":"291","author":"Uyar","year":"2015","journal-title":"Arch Gynecol Obstet."},{"issue":"9","key":"2021122821130631600_CIT0039","doi-asserted-by":"crossref","first-page":"e0162957","DOI":"10.1371\/journal.pone.0162957","article-title":"Prenatal clinical assessment of NT-proBNP as a diagnostic tool for preeclampsia, gestational hypertension and gestational diabetes mellitus","volume":"11","author":"Sadlecki","year":"2016","journal-title":"PLoS One."},{"issue":"3","key":"2021122821130631600_CIT0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1515\/cclm-2019-0939","article-title":"A more accurate prediction to rule in and rule out pre-eclampsia using the sFlt-1\/PlGF ratio and NT-proBNP as biomarkers","volume":"58","author":"Lafuente-Ganuza","year":"2020","journal-title":"Clin Chem Lab Med."},{"issue":"4","key":"2021122821130631600_CIT0041","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/10641950701548414","article-title":"Perinatal changes of circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) in normal and intrauterine-growth-restricted pregnancies","volume":"26","author":"Iacovidou","year":"2007","journal-title":"Hypertens Pregnancy."},{"issue":"2","key":"2021122821130631600_CIT0042","first-page":"137","article-title":"Accurate reference intervals are required for accurate diagnosis and monitoring of patients","volume":"19","author":"Aytekin","year":"2008","journal-title":"EJIFCC."},{"key":"2021122821130631600_CIT0043","volume-title":"Weight Gain During Pregnancy: Reexamining the Guidelines.","author":"National Research Council.","year":"2010"},{"key":"2021122821130631600_CIT0044","first-page":"1","article-title":"Reducing the risk of venous thromboembolism during pregnancy and the puerperium","volume":"37","author":"Royal College of Obstetricians and Gynaecologists.","year":"2015","journal-title":"Green-top Guideline."}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvab091\/37936901\/bvab091.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/5\/7\/bvab091\/41954940\/bvab091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/5\/7\/bvab091\/41954940\/bvab091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T16:13:41Z","timestamp":1640708021000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvab091\/6276024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,15]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvab091","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2021,5,15]]},"article-number":"bvab091"}}